MDM2 and cancer: Interestingly, upregulated mir-192 gene expression is often seen in cancers [33], and based on our modeling results we suggest that mir-192 over-expression might confer a proliferative advantage of cancer cells by simultaneous suppression of the proteins TP53, PTEN, MDM2 and CDKN1.